Key Highlights
- Tenon Medical (NASDAQ:TNON) is listed at USD 2.92, which is 17% above its 52-week low of USD 2.49 and 94.2% below its high of USD 50.40.
- Tenon Medical, a small medical device company known for its Catamaran sacroiliac joint fusion system, trades at USD 2.92 on a market value of only USD 9.249 million.
- The price is about 94% below its USD 50.40 high and only 17% above its USD 2.49 low, which reflects repeated reverse splits and dilution.
- Volume of 110,104 shares is about 0.02 times the 6.43 million average, and no company release dated October 13 was found.
The Latest Verified Updates
No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. Tenon Medical is a medical device company whose Catamaran system treats sacroiliac joint dysfunction, and it fell 2.01% to USD 2.92 on volume of 110,104 shares. A search of company filings and wire releases found no announcement dated October 13, so the move appears to be ordinary trading on an extremely small market value. The stock appears among the most heavily shorted on the screen, although a short interest percentage was not located in the material reviewed.
Short Interest, Volume and the Data
The market value of USD 9.249 million is small relative to the cost of commercializing a device, so financing is a recurring risk. The 52-week range runs from USD 2.49 to USD 50.40, so the stock is about 94% below its high, simple arithmetic, which points to reverse splits and heavy dilution. Volume of 110,104 shares is only about 2% of the 6.43 million average, so the average itself likely reflects past spikes. Simple arithmetic puts the prior close near USD 2.98, so the day's move is about USD 0.06 a share. The price sits 17% above its 52-week low and 94.2% below its high, which frames how much of the range has already been used. Volume of 110,104 shares against a three-month average of 6.430 million is 0.0 times, which is light, below average; in a heavily shorted stock, high volume can reflect short covering or new short selling, so volume alone does not reveal direction.
Risks and What to Watch
A tiny market value, recurring financing needs and a history of dilution make the stock highly speculative. What to watch next: financing, reimbursement progress and Nasdaq compliance. This is information only and not investment advice. Oil traded above USD 100 a barrel as Russia-Ukraine and Middle East developments and stalled Strait of Hormuz talks kept supply risks elevated. The big banks are reporting this week, with Bank of America and Morgan Stanley on October 14 and September CPI data due the same day.
Where Things Stand
Market conditions frame the day: oil traded above USD 100, the big banks report this week and heavily shorted technology names remain volatile. Tenon Medical (NASDAQ:TNON) is moving with routine trading on a very small market value. A drop in a heavily shorted stock can reverse quickly, so the balance of evidence favors waiting for confirmation from filings and the next session. Direction remains unknown, and the next catalyst is financing, reimbursement progress and Nasdaq compliance. Check the underlying filings first, verify the latest filings before acting, and treat the figures as a snapshot.






Please wait processing your request...